Table 1.
Characteristics of included studies
Study, Year | Study Name, Recruitment Period | Location | Inclusion Criteria | Sample Size (% Women) | Maximum Length of Follow-Up |
---|---|---|---|---|---|
Alter, 200227 | OMID, 1992–1993 | Canada | -- | 25,697 (34.8) | 5 years |
Chang, 20039 | Alberta Ministry of Health, 1993–2000 | Canada | First AMI | 22,967 (31.2) | 5 years |
Fukui, 198710 | n/a, 1975–1984 | Japan | -- | 790 (23.3) | 5 years |
Howland, 198012 | n/a, 1970–1972 | US | -- | 224 (27.7) | 5 years |
Kambara, 199515 | KYSMI, 1983–1987 | Japan | Coronary angiography within 3 months | 1000 (18.7) | 5 years |
Kishpaugh, 198117 | n/a, 1970–1972 | US | -- | 2020 (24.9) | 5 years |
Koek, 200636 | Dutch National Hospital Discharge Register, 1995 | The Netherlands | First AMI | 21,565 (32.9) | 5 years |
Lowel, 200019 | MONICA, 1985–1992 | Germany | First AMI Aged <74 years |
2210 (25.6) | 5 years |
Machon, 201020 | IBERICA, 1997–2000 | Spain | -- | 1677 (26.8) | 5 years |
Perers, 200741 | Goteborg Swedish Register, 1995–1999 | Sweden | STEMI, aged <80 years | 546 (30.6) | 5 years |
Hosmane, 200934 | n/a, 2002–2006 | US | Cardiac arrest followed by emergent PCI | 98 (29.6) | 5.5 years |
Anabitarte, 200928 | Triemli, 1995-? | Switzerland | PCI | 978 (19.0) | 6 years |
Hellermann, 200533 | Rochester Epidemiology Project, 1979–1981 | US | Heart failure | 791 (52.7) | 6.6 years |
Setoguchi, 200843 | n/a, 1999–2000 | US | -- | 1625 (80.5) | 6.6 years |
Bufe, 20107 | n/a, 1999–2001 | Germany | PCI | 500 (24.8) | 7 years |
Karp, 200716 | Quebec Hospital Discharge Database, 1998–2004 | Canada | -- | 38,543 (38.2) | 7 years |
Abdulla, 200126 | TRACE, 1990–1992 | Denmark | -- | 6676 (33.0) | 8 years |
Grundtvig, 201132 | n/a, 1998–2005 | Norway | -- | 2281 (36.8) | 8 years |
Iribarren, 200513 | n/a, 1995–2002 | US | -- | 30,324 (33.2) | 8 years |
Van Jaarsveld, 200644 | Groningen Longitudinal Aging Study, 1993–1998 | The Netherlands | -- | 198 (38.4) | 8 years |
Martin, 198338 | Perth Coronary Register, 1970–1971 | Australia | Aged 30–69 years | 666 (25.1) | 9 years |
Reynolds, 201242 | OAT, 2000–2006 | US | Total occlusion of infarct- related artery | 2201 (22.0) | 9 years |
Schreiner, 200123 | FINMONICA, 1983–1990 | Finland | Aged 25–64 years | 4900 (25.4) | 9 years |
Capewell, 20008 | Scottish Morbidity Record, 1986–1995 | Scotland | First AMI | 117,718 (41.8) | 10 years |
Galatius-Jensen, 199630 | Danish Verparamil Infarction Trial, 1979–1981 | Denmark | Aged <76 years | 3073 (24.0) | 10 years |
He, 199411 | n/a, 1974–1986 | China | First AMI | 895 (32.8) | 10 years |
Langorgen, 200918 | Western Norway CV Registry, 1979–2001 | Norway | First AMI | 11878 (35.7) | 10 years |
Murabito, 199339 | Framingham Heart Study, 1951–1986 | US | -- | 385 (30.7) | 10 years |
Welin, 200045 | Goteborg Swedish Register, 1985–1987 | Sweden | Aged <65 years | 275 (16.4) | 10 years |
Johansson, 198335 | Goteborg Swedish Register, 1968–1977 | Sweden | Age <65 years | 1521 (17.2) | 12 years |
Marrugat, 199321 | REGICOR, 1978–1988 | Spain | Age <74 years | 1216 (15.9) | 12 years |
Nicolau, 200422 | n/a, 1985–1997 | Brazil | STEMI treated with streptokinase | 686 (19.1) | 12 years |
Benderly, 19976 | SPRINT, 1981–1983 | Israel | -- | 4808 (23.3) | 13 years |
Lawesson, 201237 | RIKS-HIA, 1995–2006 | Sweden | STEMI | 54,146 (34.9) | 13 years |
Chan, 198929 | n/a, 1971–1981 | Scotland | Resuscitation from ventricular fibrillation | 75 (29.3) | 14 years |
Goldberg, 199331 | Worcester Heart Attack Study, 1975–1981 | US | -- | 3148 (39.1) | 14 years |
Singer, 199524 | Rochester Epidemiology Project, 1960–1979 | US | -- | 1608 (38.0) | 23 years |
Nauta, 201240 | n/a, 1985–2008 | The Netherlands | -- | 14,434 (27.9) | 20 years |
Isaksson, 201114 | Northern Swedish MONICA, 1985–2006 | Sweden | Age 25–64 years | 8630 (21.6) | 23 years |
Abbreviations: AMI, acute myocardial infarction; n/a, not applicable; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.